Loading…
Biofourmis acquired Swiss wearable biosensor company Biovotion for cash and equity, including its Everion device and patents. Separately, Biofourmis partnered with Novartis for commercial rollout of a heart failure management platform using AI and the Everion sensor, starting in Asia.